What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Vall d'Hebron participa en el projecte DECISION amb l'objectiu de reduir el nombre de morts en pacients de cirrosi Durant els pròxims cinc anys i mig, el consorci analitzarà i integrarà les dades clíniques existents i les mostres biològiques de 2.200 pacients amb cirrosi per identificar noves teràpies combinatòries, validar-les en models animals i després avaluar la teràpia més prometedora en un assaig clínic. News Vall d'Hebron will study whether monogenic defects condition a worse prognosis of COVID-19 in patients without comorbidities The aim is to decipher in depth the molecular, cellular, and immunological mechanisms by which they actually cause resistance to viral infection or predisposition to severe disease. News Aconsegueixen l’alliberament intracel·lular d’anticossos dirigits a bloquejar SMC2 contra cèl·lules mare tumorals La inhibició de SMC2 seria una bona estratègia contra el càncer si els anticossos arriben al nucli i al citoplasma de la cèl.lula i es pot aconseguir amb una micel.la polimèrica. News Two VHIR research projects in Covid-19 will receive funding from the Department of Health The projects are led by doctors María José Buzón and Meritxell Genescà, and by Josep Quer and Andrés Antón, respectively. News The Murga de La Llagosta collaborates with 3,267 euros for the ALS investigation It is 15 years of continuous contributions to the investigation of this disease in the VHIR Peripheral Nervous System group. News Dr. Marta Martínez Vicente obtains a grant from the BBVA Foundation for Parkinson's research The NANO-ERT project proposes the design and development of a new enzyme replacement therapy based on the administration of the recombinant GBA protein improved by nanotechnology. News Dr. Víctor Puntes collaborates in notebooks to educate and entertain girls and boys during confinement The first notebook tries to answer questions and concerns about the coronavirus and contains images of inorganic nanoparticles extracted by Dr. Víctor Puntes. News Vall d'Hebron researchers have sequenced the SARS-CoV-2 virus genome of two patients In record time and with our own resources, we have been able to develop the massive sequencing methodology to obtain the complete genome of the SARS-CoV-2 virus and from now on be able to do it in more patients. News Vall d'Hebron enrolled the first patient in Catalonia in an international clinical trial with sarilumab in patients with severe COVID-19 The drug being used, sarilumab, may be useful in reducing the acute respiratory distress syndrome seen in patients with severe COVID-19 infection. News Influencer Dulceida launches a crowfunding campaign to raise funds for Vall d'Hebron for the research into coronavirus At first, the #SOMOSUNO campaign will have two beneficiaries: the Vall d'Hebron investigation and the Madrid Health Department, but it will add new proposals. News Dr Ricard Ferrer, head of the Shock, Organic Dysfunction and Resuscitation Research Group leads an intensive care expert commission created in the context of COVID-19 The commission will establish homogeneous criteria for the treatment of patients with coronavirus, among other actions. News Vall d'Hebron participates in two clinical trials against the coronavirus using Remdesivir The clinical trials are indicated for patients with severe and moderate respiratory diseases and they are coordinated by Dr Benito Almirante and Dr Ricard Ferrer. News Vall d'Hebron participates in an international study to validate masitinib for amyotrophic lateral sclerosis treatment The study shows that masitinib at a dose of 4.5 mg/kg/d delays the functional deterioration of patients by 27% compared to placebo. News Join the Vall d'Hebron investigation into coronavirus! Join the Vall d'Hebron investigation into coronavirus! News Vall d'Hebron participates in an international position statement on the use of antihypertensive drugs in COVID-19 patients Currently, in the absence of scientific evidence, a withdrawal of ACEis or ARBs is not recommended in hypertensive patients. News Nanocapsules “3-in-1” for in vivo biomedical imaging Researchers synthesized drug delivery nanocapsules with three contrast agents for biomedical imaging techniques to study their biodistribution. News NCAM2 protein plays a decisive role in the formation of structures for cognitive learning This study explores for the first time the activity of NCAM2 in the cortex and the hippocampus, brain structures where the function of this factor was still unknown. News Vall d’Hebron participates in an international study that completes the largest genetic map of psychiatric disorders so far The study analyzes the shared genetic basis of eight psychiatric pathologies and defines three groups of genetically related disorders. News The Microbiology Research group has been funded with a LLAVOR project for repositioning nucleoside analogues as new antibacterial drugs to fight against multidrug-resistant bacteria The results will allow the development of novel and effective therapeutic strategies to treat infections that do not have any other viable approach. News Nurse Nadia Puertas receives the Patient Value Grant for a project on epilepsy The project is to evaluate the effectiveness of an educational intervention through audiovisual capsules in patients with epilepsy. Pagination First page « Previous page ‹ … Page 73 Page 74 Current page 75 Page 76 Page 77 … Next page › Last page »
